Nausea is a state of stomach distress with an urge to vomit. Common indications of nausea are motion sickness, seasickness, medication and chemotherapy. Stomach ulcers can also cause nausea. Medications and proper dietary habits can treat nausea.
Rising prevalence of gastrointestinal diseases, such as Gastroesophageal Reflux Disease (GERD), and viral gastroenteritis, and availability of a wide range of treatment options drive the market growth. Furthermore, changing lifestyle and dietary habits also influence the market.
The global nausea medicine market is expected to grow at a CAGR of 7.2% during the forecast period.
Key Players in the Global Nausea Medicine Market
Some of the key players in this market are Merck & Co., Inc. (U.S.), Sanofi (France), TESARO, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer (U.S.), GlaxoSmithKline (U.S.), ANI Pharmaceuticals, Inc. (U.S.).
Segments
The global nausea medicine market is segmented on the basis of type, mode of administration, indication and end user.
On the basis of type, market is segmented into antacids, antagonists, anti-anxiety drugs, steroids, Cannabinoids and Others.
Antacids are further segmented into serotonin (5-HT3) antagonists, NK-1 antagonists and dopamine antagonists.
On the basis of mode of administration, the market is segmented into IVs, tablets and others.
On the basis of indication, the market is segmented into gastroesophageal reflux disease (GERD), viral gastroenteritis, motion sickness and seasickness, medication, chemotherapy and others.
On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies and others.
Request Customization
Get a Sample
Get a Sample
Request Customization